Quick Answer
GOLDENWELL BIOTECH, INC. reported Gross Profit of $64.00 for the year ending 2024.
- GOLDENWELL BIOTECH, INC. showed a decrease of -90.4% in Gross Profit from 2023 to 2024.
- This data is from GOLDENWELL BIOTECH, INC.'s annual report (Form 10-K), filed with the SEC on May 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $0.00 | Q1 2020: $0.00 | Q3 2020: $0.00 | Q1 2021: $0.00 | Q2 2021: $581.00 | Q3 2021: $6.4 thousand | Q1 2022: $209.00 | Q2 2022: $2.0 thousand | Q3 2022: $23.0 thousand | Q4 2022: $0.00 | Q1 2023: $711.00 | Q2 2023: $138.00 | Q3 2023: $186.00 | Q4 2023: $73.00 | Q1 2024: $0.00 | Q2 2024: $70.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $37.5 thousand | Q3 2025: $25.0 thousand.
- Historical annual values: Fiscal year 2024: $64.00 | Fiscal year 2023: $666.00 | Fiscal year 2022: $25.2 thousand | Fiscal year 2021: $8.4 thousand | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: